Please login to the form below

Not currently logged in
Email:
Password:

Bayer veteran joins Aurinia as CEO

Stephen Zaruby spent 20 years at German pharma company
Aurinia Stephen Zaruby

Aurinia Pharmaceuticals has appointed Stepen Zaruby as president and CEO.

His career includes a 20-year stint at German company Bayer, including spells managing its domestic and international anti-infectives, quinolone and hospital/surgical business franchises.

Mmost recently he served as president at ZymoGenetics until its acquisition by Bristol-Myers Squibb in 2010. Since then he has worked as an independent consultant in life sciences.

Commenting on his latest appointment, Zaruby said he was looking forward to the future for kidney-focused Aurinia as it looks to launch its first drug.

“Aurinia is well positioned to bring voclosporin forward as an important new treatment for lupus nephritis,” he said.

Aurinia's chair Dr Richard Glickman said: “Stephen is a seasoned leader with a strong track record of delivering strategic direction and operational excellence to both established and emerging life sciences companies.

“He is exceptionally qualified to help us build our voclosporin franchise and sharpen our execution."

11th November 2013

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

Solaris Health looks at the gene therapy revolution
Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...

Infographics